authors julie-patient 
LexBlog IP
AUGUST 16, 2022
In July 2022, clinical trial data was published from a real-life retrospective observational study of pediatric (<18 years) and geriatric (≥65 years) patients with psoriasis in Italy. A total of 11 children and 23 elderly psoriasis patients were enrolled. Patients received either adalimumab or etanercept biosimilars.
SpicyIP
OCTOBER 31, 2023
[ This post is authored by SpicyIP Intern Tejaswini Kaushal with inputs and comments from Swaraj and Praharsh. In July 2021, the wife was diagnosed with metastatic HR+/HER2- Breast Cancer, for which she was prescribed Ribociclib (INR 58,140 per month), Letrozole (INR 1027.75 Tejaswini is a 3rd-year B.A. of GDP in FY23.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
LexBlog IP
JULY 21, 2023
On July 14, Dong-A ST announced that the European Medicines Agency accepted its Marketing Authorization Application (MAA) for DMB-3115, a biosimilar referencing STELARA (ustekinumab). STELARA is approved for the treatment of plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.
LexBlog IP
AUGUST 9, 2021
As the world came to a screeching halt, healthcare providers and essential businesses were tasked with maintaining function while protecting patients, employees, and customers amidst a rapidly changing health and technological landscape. Telemedicine is the use of telecommunications to deliver medical care to patients from a distance.
Fish & Richardson Trademark & Copyright Thoughts
MARCH 8, 2021
Fish attorneys Jenny Shmuel , Philip Chen , and Kayleigh McGlynn authored a Biosimilar Development article, “ Regulatory And Legislative Actions Set The Tone For Biosimilars In 2021.” Already, FDA has licensed almost 30 biosimilars, nearly 20 of which are available to patients in the United States. Biosimilar Regulatory Updates.
IP and Legal Filings
SEPTEMBER 28, 2021
However, the proposal observes that Intellectual Property Rights (IPR) has managed to potentially hinder the timely provisioning of affordable medical products and facilities to COVID 19 patients. TRIPS Council meeting, which was held on 20 th July 2021. LinkedIn.
The IPKat
SEPTEMBER 12, 2021
Most UK diabetes patients monitor their glucose levels using the "fingerprick" method. But around 30% of patients require the more sophisticated method called "continuous glucose monitoring" or CGM. Abbott commenced its expedition application on 14 July to expedite its revocation claim of four of Dexcom's patents.
Expert insights. Personalized for you.
52 
Let's personalize your content